Opinions
Glenn Paradis, BA, CFA
Gemini Gemonics PLC
GMNI-Q
DON'T BUY
Oct 13, 2000
Still have to have their technology valuated
$10.000
Stock price when the opinion was issued
biotechnology
pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
Advertising